2型糖尿病心脏自主神经病变合并视网膜病变和肾病的临床研究

田丽娜, 牛奔, 朱恩仙, 谢亚娟

PDF(604 KB)
PDF(604 KB)
重庆医科大学学报 ›› 2024, Vol. 49 ›› Issue (01) : 18-23. DOI: 10.13406/j.cnki.cyxb.003416
临床研究 DOI:10.13406/j.cnki.cyxb.003416

2型糖尿病心脏自主神经病变合并视网膜病变和肾病的临床研究

作者信息 +

A clinical study of cardiac autonomic neuropathy with retinopathy and nephropathy in patients with type 2 diabetes mellitus

Author information +
History +

摘要

目的 探讨2型糖尿病心脏自主神经病变合并视网膜病变和肾病的患病率及危险因素。 方法 选取2022年5月至2023年5月于云南省第一人民医院内分泌科住院的2型糖尿病(type 2 diabetes mellitus,T2DM)患者203例,以心血管反射试验(cardiovascular autonomic reflex tests,CARTs)结合评分判定糖尿病心脏自主神经病变(diabetic cardiac autonomic neuropathy,CAN),按照是否合并糖尿病视网膜病变(diabetic retinopathy,DR)、糖尿病肾脏病变(diabetic kidney disease,DKD)分为单纯CAN组、CAN合并DR组、CAN合并DKD组及CAN合并DR、DKD组,收集所有受试者的临床相关资料。采用SPSS 26.0软件进行统计学分析。 结果 ①203例T2DM患者中,CAN的患病率为58.62%,CAN合并DR、CAN合并DKD及CAN合并DR、DKD的患病率分别为10.08%、7.56%、10.92%。②在4组中年龄、糖化血红蛋白(glycosylated hemoglobin,HbA1c)、估算肾小球滤过率(estimated glomerular filtration rate,eGFR)、乳酸脱氢酶(lactate dehydrogenase,LDH)、直接胆红素(direct bilirubin,DBIL)、72 h动态血糖葡萄糖在目标范围内时间(72 hours dynamic blood glucose within the target range of time,TIR)等因素差异有统计学意义(P<0.05)。③Logistic回归分析结果:HbA1c(OR=2.948,95%CI=1.015~8.560,P=0.047)、LDH(OR=1.151,95%CI=1.035~1.280,P=0.010)为CAN合并DR、DKD发生发展的促进因素;DBIL(OR=0.057,95%CI=0.005~0.658,P=0.022)、eGFR(OR=0.700,95%CI=0.513~0.955,P=0.025)、TIR(OR=0.877,95%CI=0.775~0.992,P=0.037)、年龄(OR=0.550,95%CI=0.349~0.868,P=0.010)的水平与CAN合并DR、DKD的发生发展相关。 结论 较低的eGFR、TIR、DBIL、年龄与CAN合并DR、DKD的发生呈负相关,较高的HbA1c、LDH与CAN合并DR、DKD的发生呈正相关,故在eGFR、TIR、DBIL、年龄相对偏低和(或)HbA1c、LDH相对偏高的糖尿病人群中需更注重CAN合并DR、DKD的筛查。

Abstract

Objective To investigate the prevalence of cardiac autonomic neuropathy(CAN) with retinopathy and nephropathy in patients with type 2 diabetes mellitus(T2DM) and associated risk factors. Methods A total of 203 patients with T2DM who were hospitalized in the Department of Endocrinology of The First People’s Hospital of Yunnan Province from May 2022 to May 2023 were included. CAN was determined based on the scores of cardiovascular autonomic reflex tests. According to the presence or absence of diabetic retinopathy(DR) and diabetic kidney disease(DKD),the patients with CAN were divided into CAN alone group,CAN+DR group,CAN+DKD group,and CAN+DR+DKD group. The clinical data of all subjects were collected for statistical analysis using SPSS 26.0 software. Results Among the 203 patients with T2DM,the prevalence rate of CAN was 58.62%,with the prevalence rate of CAN+DR,CAN+DKD,CAN+DR+DKD being 10.08%,7.56%,and 10.92%,respectively. There were significant differences between the four groups in age,glycosylated hemoglobin(HbA1c),estimated glomerular filtration rate(eGFR),lactate dehydrogenase(LDH),direct bilirubin(DBIL),and the amount of time for blood glucose levels in the target range over 72 hours(TIR)(P<0.05). The logistic regression analysis showed that HbA1c(odds ratio[OR]=2.948,95%CI=1.015-8.560,P=0.047) and LDH(OR=1.151,95%CI=1.035-1.280,P=0.010) were factors promoting the development and progression of CAN with DR and DKD; and DBIL(OR=0.057,95%CI=0.005-0.658,P=0.022),eGFR(OR=0.700,95%CI=0.513-0.955,P=0.025),TIR(OR=0.877,95%CI=0.775-0.992,P=0.037),and age(OR=0.550,95%CI=0.349-0.868,P=0.010) were significantly associated with the development and progression of CAN with DR and DKD. Conclusion Lower eGFR,TIR,DBIL,and age are negatively correlated with the occurrence of CAN with DR and DKD,while higher HbA1c and LDH are positively correlated with the occurrence of CAN with DR and DKD. Therefore,more attention should be paid to screening for CAN with DR and DKD in patients with T2DM with low eGFR,TIR,DBIL,age and/or high HbA1c and LDH.

关键词

2型糖尿病 / 心脏自主神经病变 / 糖尿病微血管病变 / 患病率 / 危险因素

Key words

type 2 diabetes mellitus / cardiac autonomic neuropathy / diabetic microangiopathy / prevalence rate / risk factor

中图分类号

R587.2

引用本文

导出引用
田丽娜 , 牛奔 , 朱恩仙 , . 2型糖尿病心脏自主神经病变合并视网膜病变和肾病的临床研究. 重庆医科大学学报. 2024, 49(01): 18-23 https://doi.org/10.13406/j.cnki.cyxb.003416
Tian Lina, Niu Ben, Zhu Enxian, et al. A clinical study of cardiac autonomic neuropathy with retinopathy and nephropathy in patients with type 2 diabetes mellitus[J]. Journal of Chongqing Medical University. 2024, 49(01): 18-23 https://doi.org/10.13406/j.cnki.cyxb.003416

参考文献

1
Williams S Raheim SA Khan MI,et al. Cardiac autonomic neuropathy in type 1 and 2 diabetes:epidemiology,pathophysiology,and management[J]. Clin Ther202244(10):1394-1416.
2
Duque A Mediano MFF de Lorenzo A,et al. Cardiovascular autonomic neuropathy in diabetes:Pathophysiology,clinical assessment and implications[J]. World J Diabetes202112(6):855-867.
3
牛 奔,苏 恒,李超,等. 2型糖尿病外周感觉神经病变和心自主神经病变关系的研究[J]. 中国糖尿病杂志201321(2):139-141.
Niu B Su H Li C,et al. Relationship between peripheral neuropathy and cardiovascular autonomic neuropathy in type 2 diabetes[J]. Chin J Diabetes201321(2):139-141.
4
Sacchetta L Chiriacò M Nesti L,et al. Synergistic effect of chronic kidney disease,neuropathy,and retinopathy on all-cause mortality in type 1 and type 2 diabetes:a 21-year longitudinal study[J]. Cardiovasc Diabetol202221(1):233.
5
凌丹芸,汤正义,张 炜,等. 导致2型糖尿病心血管自主神经病变的主要危险因素及其对病情评估的价值[J]. 中华内科杂志200645(10):815-819.
Ling DY Tang ZY Zhang W,et al. Risk factors for cardiovascular autonomic neuropathy and their prognostic implications in type 2 diabetes mellitus[J]. Chin J Intern Med200645(10):815-819.
6
Pan Q Li QM Deng W,et al. Prevalence and diagnosis of diabetic cardiovascular autonomic neuropathy in Beijing,China:a retrospective multicenter clinical study[J]. Front Neurosci201913:1144.
7
Didangelos T Veves A. Treatment of diabetic cardiovascular autonomic,peripheral and painful neuropathy. focus on the treatment of cardiovascular autonomic neuropathy with ACE inhibitors[J]. Curr Vasc Pharmacol202018(2):158-171.
8
Asghar S Asghar S Shahid S,et al. Metabolic syndrome in type 2 diabetes mellitus patients:prevalence,risk factors,and associated microvascular complications[J]. Cureus202315(5):e39076.
9
Agashe S Petak S. Cardiac autonomic neuropathy in diabetes mellitus[J]. Methodist Debakey Cardiovasc J201814(4):251-256.
10
Spallone V. Update on the impact,diagnosis and management of cardiovascular autonomic neuropathy in diabetes:what is defined,what is new,and what is unmet[J]. Diabetes Metab J201943(1):3-30.
11
Varley BJ Gow ML Cho YH,et al. Higher frequency of cardiovascular autonomic neuropathy in youth with type 2 compared to type 1 diabetes:role of cardiometabolic risk factors[J]. Pediatr Diabetes202223(7):1073-1079.
12
Nanayakkara N Curtis AJ Heritier S,et al. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications:systematic review and meta-analyses[J]. Diabetologia202164(2):275-287.
13
辛 宁. 合并不同慢性并发症的2型糖尿病患者血清胰岛素、糖化血红蛋白水平及其临床意义[J]. 临床研究202028(4):100-101.
Xin N. Serum insulin and glycosylated hemoglobin levels in patients with type 2 diabetes mellitus complicated with different chronic complications and their clinical significance[J]. Clin Res202028(4):100-101.
14
Li YL Yi M Deng XY,et al. Evaluation of the thyroid characteristics and correlated factors in hospitalized patients with newly diagnosed type 2 diabetes[J]. Diabetes Metab Syndr Obes202215:873-884.
15
Hu YH Hu ZB Tang WN,et al. Association of thyroid hormone levels with microvascular complications in euthyroid type 2 diabetes mellitus patients[J]. Diabetes Metab Syndr Obes202215:2467-2477.
16
Wan H Wang YY Fang SJ,et al. Associations between the neutrophil-to-lymphocyte ratio and diabetic complications in adults with diabetes:a cross-sectional study[J]. J Diabetes Res20202020:6219545.
17
He XJ Qi SS Zhang X,et al. The relationship between the neutrophil-to-lymphocyte ratio and diabetic retinopathy in adults from the United States:results from the National Health and nutrition examination survey[J]. BMC Ophthalmol202222(1):346.
18
Allwright M Karrasch JF O'Brien JA,et al. Machine learning analysis of the UK Biobank reveals prognostic and diagnostic immune biomarkers for polyneuropathy and neuropathic pain in diabetes[J]. Diabetes Res Clin Pract2023201:110725.
19
Laiteerapong N Ham SA Gao Y,et al. The legacy effect in type 2 diabetes:impact of early glycemic control on future complications(the diabetes & aging study)[J]. Diabetes Care201942(3):416-426.
20
Meher M Panda JK. Impact of glycemic control over cardiac autonomic neuropathy[J]. J Diabetes Metab Disord202019(2):1339-1344.
21
Raj R Mishra R Jha N,et al. Time in range,as measured by continuous glucose monitor,as a predictor of microvascular complications in type 2 diabetes:a systematic review[J]. BMJ Open Diabetes Res Care202210(1):e002573.
22
Sheng X Xiong GH Yu PF,et al. The correlation between time in range and diabetic microvascular complications utilizing information management platform[J]. Int J Endocrinol20202020:8879085.
23
Lai YC Li HY Jiang YD,et al. Decreased glomerular filtration rate and increased albuminuria for identification of cardiovascular autonomic neuropathy in subjects with and without diabetes[J]. Auton Neurosci2021230:102757.
24
Jun JE Choi MS Kim JH. Cardiovascular autonomic neuropathy and incident diabetic kidney disease in patients with type 2 diabetes[J]. Diabetes Res Clin Pract2022184:109181.
25
Babaliche P Nadpara RA Maldar A. Association between estimated glomerular filtration rate and microvascular complications in type II diabetes mellitus patients:a 1-year cross-sectional study[J]. J Natl Med Assoc2019111(1):83-87.
26
Hsieh YS Yeh MC Lin YY,et al. Is the level of serum lactate dehydrogenase a potential biomarker for glucose monitoring with type 2 diabetes mellitus?[J]. Front Endocrinol202213:1099805.
27
Zhu Y Li XY Wang J,et al. Bradykinin alleviates DR retinal endothelial injury by regulating HMGB-1/NF-κB pathway[J]. Eur Rev Med Pharmacol Sci201923(13):5535-5541.
28
Rashid MM Rahman MA Islam MS,et al. Natural compounds of Lasia spinosa(L) stem potentiate antidiabetic actions by regulating diabetes and diabetes-related biochemical and cellular indexes[J]. Pharmaceuticals202215(12):1466.
29
Wan H Zhu H Wang YY,et al. Associations between different bilirubin subtypes and diabetic microvascular complications in middle-aged and elderly individuals[J]. Ther Adv Endocrinol Metab202011:2042018820937897.
30
罗 瑾,黄文勇,黎宇婷,等. 威胁视力的2型糖尿病视网膜病变风险预测模型的建立与验证[J]. 中山大学学报(医学科学版)202344(6):999-1007.
Luo J Huang WY Li YT,et al. Development and validation of a predictive risk model for vision-threatening diabetic retinopathy in patients with type 2 diabetes[J]. J Sun Yat Sen Univ Med Sci202344(6):999-1007.
31
郭青玉,宋雯婧,许邵莹,等. 2型糖尿病患者血清胆红素与心血管自主神经病变的相关性[J]. 中华医学杂志201999(40):3132-3138.
Guo QY Song WJ Xu SY,et al. Correlation between serum bilirubin and cardiovascular autonomic neuropathy in patients with type 2 diabetes[J]. Natl Med J China201999(40):3132-3138.

基金

国家自然科学基金资助项目(81960150)
云南省中青年学术和技术带头人后备人才基金资助项目(202105AC160028)
云南省董碧蓉专家工作站资助项目(202105AF150032)
云南省老年疾病临床医学研究中心资助项目(202102AA310002)
云南省兴滇英才支持计划“医疗卫生人才专项”资助项目

评论

PDF(604 KB)

Accesses

Citation

Detail

段落导航
相关文章

/